INM
InMed Pharmaceuticals Inc. Common Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
INM Stock Analysis: Buy, Sell, or Hold?
$15.56
+2.35 (+17.79%)
▲
5d:
+872.5%
30d:
+1069.92%
90d:
+1003.55%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
35/100
Position
EXTENDED
30-Day Fair Range
$-1.08 – $6.24
Position: EXTENDED
Wall Street Target
$20.00
+28.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.41 / $16.44
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: INM is 149.4% above its trading range ($6.24). While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When INM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INM is currently trading at $15.56, which is considered extended relative to its 30-day fair value range of $-1.08 to $6.24.
Technical Outlook: Technically, INM is showing sideways momentum. Immediate support is located at $1.41, while resistance sits at $16.44. The stock is showing strong short-term momentum, up 17.8% recently.
Market Sentiment: INM scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+28.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INM is showing sideways momentum. Immediate support is located at $1.41, while resistance sits at $16.44. The stock is showing strong short-term momentum, up 17.8% recently.
Market Sentiment: INM scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+28.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-1.08 -
$6.24
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$-1.08 -
$6.24
Current vs Trading Range
EXTENDED
Support Level
$1.41
Resistance Level
$16.44
Current Trend
Sideways
Technical data as of
Nov 6, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Technical Setup Structure
MONITORING
Absorption:
Inactive (CMF 0.17)
Pullback / Drawdown:
-0.0% from 52W High
Consolidation:
Trending (ADX 49.7)
30D Insider Cluster Signal
CLUSTER BUY
30D Insider Buyers:
2 insiders ($33,401)
30D Net Insider Flow:
+$33,401
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+149.4% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+17.8%)
- BULLISH: Trading 28.5% below Wall St target ($20.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Wall Street Target
$20.00
(+28.5%)
Revenue Growth (YoY)
-26.2%
Share INM Analysis
Share this live INM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INM)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 7, 2026
Daily AI digest
AI Retail Discussion Summary:
InMed Pharmaceuticals has completed its merger with Mentari Therapeutics and announced the trading of its shares on Nasdaq under the ticker symbol 'MTRI' starting November 9, 2026. The company raised approximately $490 million in gross proceeds during the merger.
Key Retail Themes:
Merger completion and trading on Nasdaq
Fundraising and proceeds from the merger
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 8:41 PM ET
Data refreshes hourly during market hours. Next update: 9:41 PM
Data refreshes hourly during market hours. Next update: 9:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
28 analysts |
$208 | 30 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 39 SELL |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 47 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 55 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 59 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INM Research Pages
Part B: Tradestie Flagship Market Scanners